BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32153569)

  • 1. Editorial: Strategies for Modulating T Cell Responses in Autoimmunity and Infection.
    Pascutti MF; Martinez GJ; Quiroga MF
    Front Immunol; 2020; 11():208. PubMed ID: 32153569
    [No Abstract]   [Full Text] [Related]  

  • 2. Revisiting the Functional Impact of NK Cells.
    Poli A; Michel T; Patil N; Zimmer J
    Trends Immunol; 2018 Jun; 39(6):460-472. PubMed ID: 29496432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Vaccine and Immunotherapy Design Using Biomaterials.
    Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
    Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of infection in the pathogenesis of autoimmune disease.
    Rose NR
    Semin Immunol; 1998 Feb; 10(1):5-13. PubMed ID: 9529651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell metabolism in metabolic disease-associated autoimmunity.
    Amersfoort J; Kuiper J
    Immunobiology; 2017 Oct; 222(10):925-936. PubMed ID: 28363498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunity.
    von Herrath M; Homann D
    Trends Immunol; 2003 Oct; 24(10):540-5. PubMed ID: 14552838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell targeted immunotherapy for autoimmune disease.
    Lee E; Sinha AA
    Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview.
    Dolatkhah K; Alizadeh N; Mohajjel-Shoja H; Abdoli Shadbad M; Hajiasgharzadeh K; Aghebati-Maleki L; Baghbanzadeh A; Hosseinkhani N; Karim Ahangar N; Baradaran B
    Int J Rheum Dis; 2022 Mar; 25(3):259-271. PubMed ID: 34994525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(4):260a. PubMed ID: 29176288
    [No Abstract]   [Full Text] [Related]  

  • 10. Report about the XVIIIth meeting of the Cancer Research Institute in its international cancer immunotherapy symposium series on October 6-8, 2010.
    Hockertz S
    Toxicology; 2011 Jan; 279(1-3):203-7. PubMed ID: 21204306
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting B cells in treatment of autoimmunity.
    Franks SE; Getahun A; Hogarth PM; Cambier JC
    Curr Opin Immunol; 2016 Dec; 43():39-45. PubMed ID: 27718447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of effective immunotherapy for human autoimmunity.
    Feldmann M; Steinman L
    Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmunity].
    Müller C
    Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Organ-Specific Autoimmune Diseases Including Immunotherapy.
    Mastrandrea LD
    Immunol Invest; 2015; 44(8):803-16. PubMed ID: 26575465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.
    Sautto GA; Diotti RA; Wisskirchen K; Kahle KM
    J Immunol Res; 2017; 2017():3104719. PubMed ID: 28758132
    [No Abstract]   [Full Text] [Related]  

  • 16. 4th Australasian vaccines and immunotherapeutic development meeting.
    Engwerda C; Belz G
    Immunol Cell Biol; 2012 Nov; 90(10):921-4. PubMed ID: 23190698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity.
    Lavelle EC; McLachlan JB
    Curr Opin Pharmacol; 2018 Aug; 41():vii-ix. PubMed ID: 30139514
    [No Abstract]   [Full Text] [Related]  

  • 18. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapies for memory cells in autoimmune diseases.
    Bhargava P; Calabresi PA
    Clin Exp Immunol; 2015 Jun; 180(3):353-60. PubMed ID: 25682849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.